ISCOM technology-based Matrix M™ adjuvant: Success in future vaccines relies on formulation

2011-04-01

Expert Review of Vaccines , Volume 10 - Issue 4 p. 401- 403

Additional Metadata
Keywords	ISCOM, Matrix M, Quillaja saponaria Molina, Th1/Th2, saponin, vaccine adjuvant
Persistent URL	doi.org/10.1586/erv.11.25, hdl.handle.net/1765/34396
Journal	Expert Review of Vaccines
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lövgren-Bengtsson, K., Morein, B., & Osterhaus, A. (2011). ISCOM technology-based Matrix M™ adjuvant: Success in future vaccines relies on formulation. Expert Review of Vaccines, 10(4), 401–403. doi:10.1586/erv.11.25

Publication